SCHEMBL20857035

SCHEMBL20857035

O=C(c1ccccc1)N1CCCC(N(C(=O)CCl)c2ccccc2)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MITF O75030 2/20 0.66
ALDH1A1 P00352 2/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
KDM4E B2RXH2 1/20 0.66
NPC1 O15118 1/20 0.66
RAB9A P51151 1/20 0.66
PAX8 Q06710 1/20 0.66
LMNA P02545 1/20 0.50
HTT P42858 1/20 0.50
NCOA1 Q15788 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49
CA5A P35218 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18763050 0.95 MITF (0.64) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL3121243 0.85 MEN1 (0.55) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL18770884 0.85 MITF (0.71) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL19687605 0.84 MITF (0.54) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL18792902 0.83 OPRM1 (0.65) CHRM3OPRM1SIGMAR1OPRD1
SCHEMBL5993964 0.82 ALDH1A1 (0.97) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL18763041 0.82 MITF (0.51) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL22387593 0.81 ALDH1A1 (0.46) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL5992289 0.80 ALDH1A1 (1.00) MITFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL20857033 0.80 KMT2A (0.49) MITFALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
EP-3688472-A1 CONJUGATED PROTEINS AND USES THEREOF The Scripps Research Institute (US) 2020-08-05 EP disclosed
WO-2019067741-A1 CONJUGATED PROTEINS AND USES THEREOF THE SCRIPPS RESEARCH INSTITUTE (US) 2019-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF KEAP1, GSTK1, GSTM2 MITF 978/4885ALDH1A1 1225/4885SMN1; SMN2 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.